Filter

Refine by Content Type

Refine by ASN Kidney News

  • Special Section (1)

Refine by Date

—
  • Print
  • Save

Search Results

You are looking at 1 - 1 of 1 items for :

  • Author or Editor: Anatole Besarab x
  • Special Section x
  • Refine by Content Type: All x
Clear All Modify Search
Cover Kidney News
The Scourges of the Hemodialysis Catheter
Anatole Besarab

Hemodialysis (HD) sustains life for those with ESRD. Currently, nearly 400,000 individuals in the United States receive HD as management of ESRD (1). Sustainable vascular access that provides high-volume blood flow rates (Qb) above 300 mL/min is essential, whether through arteriovenous autologous fistulas, synthetic grafts, or tunneled dialysis catheters (TDCs) (2). Unfortunately, the overwhelming majority of incident patients begin HD treatments with a TDC: 82 percent, according to the most recent data from the U.S. Renal Data System (1). More than 20 percent of prevalent patients become or remain dependent on long-term TDC use,